A. P. Maggioni, EURObservational Research Programme: Regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot), Eur. J. Heart. Fail, vol.15, pp.808-817, 2013.

V. L. Roger, Heart disease and stroke statistics-2012 update: A report from the, American Heart Association. Circulation, vol.125, pp.2-220, 2012.

P. M. Seferovic, Organization of heart failure management in European Society of Cardiology member countries: survey of the Heart Failure Association of the European Society of Cardiology in collaboration with the Heart Failure National Societies/ Working Groups, Eur. J. Heart. Fail, vol.15, pp.947-959, 2013.

P. Ponikowski, ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC, Eur. Heart J, vol.37, pp.2129-2200, 2016.

G. Savarese and L. H. Lund, Global public health burden of heart failure, Cardiac. Fail. Rev, vol.3, issue.2, pp.7-11, 2017.

S. M. Dunlay, V. L. Roger, and M. M. Redfield, Epidemiology of heart failure with preserved ejection fraction, Nat. Rev. Cardiol, vol.14, pp.591-602, 2017.

G. A. Lewis, Biological Phenotypes of Heart Failure With Preserved Ejection Fraction, J Am Coll Cardiol, vol.70, pp.2186-2200, 2017.

M. Gyongyosi, Myocardial fibrosis: biomedical research from bench to bedside, Eur. J. Heart. Fail, vol.19, pp.177-191, 2017.

E. B. Schelbert, G. C. Fonarow, R. O. Bonow, J. Butler, and M. Gheorghiade, Therapeutic targets in heart failure: Refocusing on the myocardial interstitium, J. Am. Coll. Cardiol, vol.63, pp.2188-2198, 2014.

A. H. Li, P. P. Liu, F. J. Villarreal, and R. A. Garcia, Dynamic changes in myocardial matrix and relevance to disease: Translational perspectives, Circ. Res, vol.114, p.9, 2014.

R. G. Gourdie, S. Dimmeler, and P. Kohl, Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease, Nat. Rev. Drug Discov, vol.15, pp.620-638, 2016.

J. G. Travers, F. A. Kamal, J. Robbins, K. E. Yutzey, and B. C. Blaxall, Cardiac fibrosis: The fibroblast awakens, Circ. Res, vol.118, p.5, 2016.

R. Kramann, Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis, Cell Stem Cell, vol.16, pp.51-66, 2015.

R. Kalluri, The biology and function of fibroblasts in cancer, Nat. Rev. Cancer, vol.16, pp.582-598, 2016.

, (1234567890) Scientific RepoRtS | (2020) 10:11404 |

P. Teekakirikul, Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-beta, J. Clin. Invest, vol.120, pp.3520-3529, 2010.

H. E. Olivey, N. A. Mundell, A. F. Austin, and J. V. Barnett, Transforming growth factor-beta stimulates epithelial-mesenchymal transformation in the proepicardium, Dev. Dyn, vol.235, pp.50-59, 2006.

J. Duan, Wnt1/betacatenin injury response activates the epicardium and cardiac fibroblasts to promote cardiac repair, EMBO J, vol.31, p.418, 2012.

B. D. Humphreys, Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis, Am. J. Pathol, vol.176, pp.85-97, 2010.

E. Yaniz-galende, Fibrogenic potential of PW1/Peg3 expressing cardiac stem cells, J. Am. Coll. Cardiol, vol.70, pp.728-741, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02267419

V. Besson, PW1 gene/paternally expressed gene 3 (PW1/Peg3) identifies multiple adult stem and progenitor cell populations, Proc. Natl. Acad. Sci. USA, vol.108, pp.11470-11475, 2011.

K. J. Mitchell, Identification and characterization of a non-satellite cell muscle resident progenitor during postnatal development, Nat. Cell Biol, vol.12, pp.257-266, 2010.

N. C. Henderson, Targeting of alphav integrin identifies a core molecular pathway that regulates fibrosis in several organs, Nat. Med, vol.19, pp.1617-1624, 2013.

C. Chen, R. Li, R. S. Ross, and A. M. Manso, Integrins and integrin-related proteins in cardiac fibrosis, J. Mol. Cell. Cardiol, vol.93, pp.162-174, 2016.

P. Salven, S. Mustjoki, R. Alitalo, K. Alitalo, and S. Rafii, VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells, Blood, vol.101, pp.168-172, 2003.

D. A. Skelly, Single-cell transcriptional profiling reveals cellular diversity and intercommunication in the mouse heart, Cell Rep, vol.22, pp.600-610, 2018.

F. Dierick, Resident PW1+ progenitor cells participate in vascular remodeling during pulmonary arterial hypertension, Circ. Res, vol.118, p.5, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01304194

M. Sojoodi, The zinc finger transcription factor PW1/PEG3 restrains murine beta cell cycling, Diabetologia, vol.59, pp.1474-1479, 2016.

V. Besson, Expression analysis of the stem cell marker Pw1/Peg3 reveals a CD34 negative progenitor population in the hair follicle, Stem Cells, vol.35, pp.1015-1027, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01515292

M. Korf-klingebiel, Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction, Nat. Med, vol.21, pp.140-149, 2015.

M. B. Furtado, Cardiogenic genes expressed in cardiac fibroblasts contribute to heart development and repair, Circ. Res, vol.114, p.0, 2014.

Y. Sun and K. T. Weber, Infarct scar: A dynamic tissue, Cardiovasc. Res, vol.46, pp.250-256, 2000.

H. Lorchner, Myocardial healing requires Reg3beta-dependent accumulation of macrophages in the ischemic heart, Nat. Med, vol.21, pp.353-362, 2015.

N. I. Reed, The alphavbeta1 integrin plays a critical in vivo role in tissue fibrosis, Sci. Transl. Med, vol.7, 2015.

K. P. Conroy, L. J. Kitto, and N. C. Henderson, alphav integrins: key regulators of tissue fibrosis, Cell Tissue Res, vol.365, pp.511-519, 2016.

I. R. Murray, Alphav integrins on mesenchymal cells regulate skeletal and cardiac muscle fibrosis, Nat. Commun, vol.8, 1118.

R. E. Nisato, J. C. Tille, A. Jonczyk, S. L. Goodman, and M. S. Pepper, alphav beta 3 and alphav beta 5 integrin antagonists inhibit angiogenesis in vitro, Angiogenesis, vol.6, pp.105-119, 2003.

A. L. Denizot, A novel mutant allele of Pw1/Peg3 does not affect maternal behavior or nursing behavior, PLoS Genet, vol.12, p.53, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01342013

I. Lasinska and J. Mackiewicz, Integrins as a new target for cancer treatment, Anticancer Agents Med. Chem, vol.66618, p.3413, 2018.

C. Mas-moruno, F. Rechenmacher, and H. Kessler, Cilengitide: the first anti-angiogenic small molecule drug candidate design, synthesis and clinical evaluation, Anticancer Agents Med. Chem, vol.10, pp.753-768, 2010.

C. Chen, S. S. Khaleel, H. Huang, and C. H. Wu, Software for pre-processing Illumina next-generation sequencing short read sequences, Source Code Biol. Med, vol.9, 2014.

B. Li, C. N. Dewey, and . Rsem, Accurate transcript quantification from RNA-Seq data with or without a reference genome, BMC Bioinform, vol.12, 2011.

A. Yates, Nucleic Acids Res, vol.44, pp.710-716, 2016.

A. Butler, P. Hoffman, P. Smibert, E. Papalexi, and R. Satija, Integrating single-cell transcriptomic data across different conditions, technologies, and species, Nat. Biotechnol, vol.36, pp.411-420, 2018.

, R Foundation for Statistical Computing. A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2018.

, Scientific RepoRtS |, vol.10, p.11404, 2020.